1 |
Kelly JF, Snell ME, Berenhaum MC. Photodynamic destruction of human bladder carcinoma. Br J Cancer 1975;31:237-44
|
2 |
Diaz-Jimenez JP, Martinez-Ballarin JE, Llunell A, Farrero E, Rodriguez A, Castro MJ. Efficacy and safety of photodynamic therapy versus Nd-YAG laserresection in NSCLC with airway obstruction. Eur Respir J 1999;14:800-5.
|
3 |
Lam S, Crofton C, Cory P. Combined photodynamic therapy (PDT) using Photofrin and radiotherapy (XRT) versus radiotherapy alone in patients withinoperable distribution non-small cell bronchogenic cancer. Proc Intl Soc Optical Engin 1991(SPIE) 20-8
|
4 |
Spiro SG, Porter JC. Porter, Lung Cancer-where are we today?: Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002;166:1166-96
|
5 |
Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992;102:1319-22
|
6 |
Gregorie HG. Jr, Horger EO, Ward JL. Hematoporphyrin derivative fluorescence I Malignant neoplasms. Ann Surg 1968;167:820-8
|
7 |
Moghissi K, Dixon K, Parsons RJ. A controlled trial of Nd-YAG vs Photodynamic therapy for advanced malignant bronchial obstruction. Lasers Med Sci 1993;8:269-73
|
8 |
McCaughan JS Jr. Photodynamic therapy of endobronchial and esophageal tumors: an overview. J Clin Laser Med Surg 1996;14:223-33
|
9 |
Marcus SL. Clinical photodynamic therapy: the continuing evolution. In: Henderson BW, Dougherty TJ, editors. Photodynamic therapy. New York: MarcelDekker Inc., 1992.;219-68
|
10 |
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905
|
11 |
Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997;72:595-602
|
12 |
Dougherty TJ, Kaufman JE, Goldfarb A. Weishaupt KR, Bouleo, Mzfflewar A Photoradiationtherapy for the treatment of malignant tumors. Cancer Res 1978;38:2628-35
|
13 |
Kim YS, Park JS, Jee YK, Lee KY. Photodynamic therapy induced cell death using ALA and 632nm diode Laser in A549 lung cancer cells. Tuberculosis and Respiratory Disease. 2004;56:178-86
|
14 |
Okunaka T, Kato H, Tsutsui H, Ishizumi T, Ichinose S, Kuroiwa Y. Photodynamic therapy for peripheral lung cancer. Lung Cancer 2004;43:77-82
|
15 |
Lipson RL, Baldes EJ, Gray MS. Hematoporphyrin derivative for detection and management of cancer. Cancer. 1967;20:2255-7
|
16 |
Kato H, Okunaka T, Shimatani H. Photodynamic therapy for early stage bronchogenic carcinoma. J Clin Laser Meg Surg 1996;14:235-8
|
17 |
Moghissi K, Dixon K, Stringer M, Freeman T, Thorpe A, Brown S. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg 1999;15:1-6
|
18 |
John DM. Chapter 88. Neoplasms of the lung. In:Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th Ed. New York: McGraw-Hill, Inc; 2001. p 567
|